scholarly journals PLATYPUS: A Multiple—View Learning Predictive Framework for Cancer Drug Sensitivity Prediction

Author(s):  
Kiley Graim ◽  
Verena Friedl ◽  
Kathleen E. Houlahan ◽  
Joshua M. Stuart
2018 ◽  
Vol 16 (03) ◽  
pp. 1840014 ◽  
Author(s):  
Turki Turki ◽  
Zhi Wei ◽  
Jason T. L. Wang

Transfer learning (TL) algorithms aim to improve the prediction performance in a target task (e.g. the prediction of cisplatin sensitivity in triple-negative breast cancer patients) via transferring knowledge from auxiliary data of a related task (e.g. the prediction of docetaxel sensitivity in breast cancer patients), where the distribution and even the feature space of the data pertaining to the tasks can be different. In real-world applications, we sometimes have a limited training set in a target task while we have auxiliary data from a related task. To obtain a better prediction performance in the target task, supervised learning requires a sufficiently large training set in the target task to perform well in predicting future test examples of the target task. In this paper, we propose a TL approach for cancer drug sensitivity prediction, where our approach combines three techniques. First, we shift the representation of a subset of examples from auxiliary data of a related task to a representation closer to a target training set of a target task. Second, we align the shifted representation of the selected examples of the auxiliary data to the target training set to obtain examples with representation aligned to the target training set. Third, we train machine learning algorithms using both the target training set and the aligned examples. We evaluate the performance of our approach against baseline approaches using the Area Under the receiver operating characteristic (ROC) Curve (AUC) on real clinical trial datasets pertaining to multiple myeloma, nonsmall cell lung cancer, triple-negative breast cancer, and breast cancer. Experimental results show that our approach is better than the baseline approaches in terms of performance and statistical significance.


2021 ◽  
Vol 12 ◽  
Author(s):  
Yaojia Chen ◽  
Liran Juan ◽  
Xiao Lv ◽  
Lei Shi

Modeling-based anti-cancer drug sensitivity prediction has been extensively studied in recent years. While most drug sensitivity prediction models only use gene expression data, the remarkable impacts of gene mutation, methylation, and copy number variation on drug sensitivity are neglected. Drug sensitivity prediction can both help protect patients from some adverse drug reactions and improve the efficacy of treatment. Genomics data are extremely useful for drug sensitivity prediction task. This article reviews the role of drug sensitivity prediction, describes a variety of methods for predicting drug sensitivity. Moreover, the research significance of drug sensitivity prediction, as well as existing problems are well discussed.


2018 ◽  
Vol 19 (S17) ◽  
Author(s):  
Saugato Rahman Dhruba ◽  
Raziur Rahman ◽  
Kevin Matlock ◽  
Souparno Ghosh ◽  
Ranadip Pal

Author(s):  
Noah Berlow ◽  
Saad Haider ◽  
Qian Wan ◽  
Mathew Geltzeiler ◽  
Lara E. Davis ◽  
...  

Cell Systems ◽  
2021 ◽  
Author(s):  
Marco Tognetti ◽  
Attila Gabor ◽  
Mi Yang ◽  
Valentina Cappelletti ◽  
Jonas Windhager ◽  
...  

Micromachines ◽  
2021 ◽  
Vol 12 (6) ◽  
pp. 624
Author(s):  
Qiang Liu ◽  
Tian Zhao ◽  
Xianning Wang ◽  
Zhongyao Chen ◽  
Yawei Hu ◽  
...  

Three-dimensional cultured patient-derived cancer organoids (PDOs) represent a powerful tool for anti-cancer drug development due to their similarity to the in vivo tumor tissues. However, the culture and manipulation of PDOs is more difficult than 2D cultured cell lines due to the presence of the culture matrix and the 3D feature of the organoids. In our other study, we established a method for lung cancer organoid (LCO)-based drug sensitivity tests on the superhydrophobic microwell array chip (SMAR-chip). Here, we describe a novel in situ cryopreservation technology on the SMAR-chip to preserve the viability of the organoids for future drug sensitivity tests. We compared two cryopreservation approaches (slow freezing and vitrification) and demonstrated that vitrification performed better at preserving the viability of LCOs. Next, we developed a simple procedure for in situ cryopreservation and thawing of the LCOs on the SMAR-chip. We proved that the on-chip cryopreserved organoids can be recovered successfully and, more importantly, showing similar responses to anti-cancer drugs as the unfrozen controls. This in situ vitrification technology eliminated the harvesting and centrifugation steps in conventional cryopreservation, making the whole freeze–thaw process easier to perform and the preserved LCOs ready to be used for the subsequent drug sensitivity test.


Sign in / Sign up

Export Citation Format

Share Document